Search Results
Aug 24, 2026, 06:02 ET Anderson & Vreeland Launches Innovative AVantage Liquid Resin Laboratory
research team is foundational tools to carry out their work- such as advanced instrumentation and laboratory environments," states Ryan Vest, Director of R&D and AVantage Technology. "The AVantage Technical Support and Development Laboratory is a key investment that will enable the AVantage team to further
More news about: Anderson & Vreeland Inc.
Aug 24, 2026, 05:40 ET BlueNord: Minutes from Extraordinary General Meeting - Merger Plan with Vår Energi Approved
https://news.cision.com/bluenord-asa/r/bluenord--minutes-from-extraordinary-general-meeting---merger-plan-with-var-energi-approved,c4386904The following files are available for download:
More news about: BlueNord ASA
Aug 24, 2026, 05:35 ET European Commission grants orphan designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for Cushing's syndrome of endogenous origin
important recognition of both the unmet need in Cushing's and the scientific rationale behind asedebart," said Johan Luthman, Executive Vice President, R&D, Lundbeck. "The asedebart program is a good representation of the type of strong targeted mechanism programs we like to advance in Lundbeck. The orphan
More news about: H. Lundbeck A/S
Aug 24, 2026, 05:33 ET European Commission grants orphan designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for Cushing's syndrome of endogenous origin
important recognition of both the unmet need in Cushing's and the scientific rationale behind asedebart," said Johan Luthman, Executive Vice President, R&D, Lundbeck. "The asedebart program is a good representation of the type of strong targeted mechanism programs we like to advance in Lundbeck. The orphan
More news about: H. Lundbeck A/S
Aug 24, 2026, 05:27 ET American Parkinson Disease Association Launches Spanish-Language Microsite, Expanding Support for Underserved Parkinson's Community
community that helps everyone impacted by PD live life to the fullest. Through a nationwide grassroots network of Chapters and Information & Referral (I&R) Centers, APDA works tirelessly to raise public awareness of this chronic neurologic movement disorder and deliver outstanding patient services, resources,
More news about: American Parkinson Disease Association, Inc.
Aug 24, 2026, 04:30 ET Camel Group's 12V Sodium-Ion Battery Selected for European OEM Pre-Development Project
follows the adoption of Camel Group's 12V lithium-ion batteries by major European automakers and represents another step in the company's overseas R&D collaboration in next-generation low-voltage battery technology.Sodium-ion batteries are attracting increasing attention in automotive applications
More news about: Camel Group Co.,Ltd.
Aug 24, 2026, 03:26 ET MacGregor extends Horizon gangway to floating-to-floating personnel transfer
https://news.cision.com/macgregor/r/macgregor-extends-horizon-gangway-to-floating-to-floating-personnel-transfer,c4386424The following files are available for download:
More news about: MacGregor
Aug 24, 2026, 03:20 ET MacGregor advances direct ship-to-well LCO₂ transfer, built on 50 years of proven bow-loading technology
https://news.cision.com/macgregor/r/macgregor-advances-direct-ship-to-well-lco--transfer--built-on-50-years-of-proven-bow-loading-techno,c4386403The following files are available for download:
More news about: MacGregor
Aug 24, 2026, 03:15 ET Scania to showcase its broad marine offering at SMM 2026
https://news.cision.com/scania/r/scania-to-showcase-its-broad-marine-offering-at-smm-2026,c4383473The following files are available for download:
More news about: Scania
Aug 24, 2026, 03:06 ET Share buybacks in Ericsson during the period August 17 - August 21, 2026
https://news.cision.com/ericsson/r/share-buybacks-in-ericsson-during-the-period-august-17---august-21--2026,c4386704The following files are available for download:
More news about: Ericsson
Aug 24, 2026, 03:02 ET Share buybacks in Ericsson during the period August 17 - August 21, 2026
https://news.cision.com/ericsson/r/share-buybacks-in-ericsson-during-the-period-august-17---august-21--2026,c4386704The following files are available for download:
More news about: Ericsson
Aug 24, 2026, 03:01 ET ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
rare diseases, announced that it has been finally selected for the 2026 Investment and Financing-Linked Technology Development Program (Global TIPS R&D), organized by the Ministry of SMEs and Startups (MSS) and the Korea Technology and Information Promotion Agency for SMEs (TIPA).
More news about: ImmunoForge Co., Ltd.
Aug 24, 2026, 02:25 ET NKT qualifies 525 kV HVDC subsea power cable system for operation at 90 °C
https://news.cision.com/nkt/r/nkt-qualifies-525-kv-hvdc-subsea-power-cable-system-for-operation-at-90--c,c4386800The following files are available for download:
More news about: NKT
Aug 24, 2026, 01:48 ET Skanska to build datacenter near Prague, Czechia, for CZK 2.1 billion, about SEK 930M
https://news.cision.com/skanska/r/skanska-to-build-datacenter-near-prague--czechia--for-czk-2-1-billion--about-sek-930m,c4386683The following files are available for download:
More news about: Skanska
Aug 24, 2026, 01:21 ET GC Biopharma's Hunter Syndrome Treatment 'Hunterase' Receives Drug Approval in India and Taiwan
immunoglobulin G) in 2024. In line with its mission to meet the demands of future healthcare, GC Biopharma continues to drive innovation by leveraging its core R&D capabilities in engineering of proteins, mRNAs, and lipid nanoparticle (LNP) drug delivery platform to develop therapeutics for the field of rare disease
More news about: GC Biopharma
Aug 24, 2026, 01:03 ET Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
Genentech will take over development starting with Phase 2 clinical trials.In-Young Choi, Senior Executive Vice President, Head of R&D Division of Hanmi Pharm stated, "The paradigm of obesity treatment is evolving beyond simple weight reduction toward improving body composition and
More news about: Hanmi Pharm. Co., Ltd.
Aug 24, 2026, 00:40 ET Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
Genentech will take over development starting with Phase 2 clinical trials.In-Young Choi, Senior Executive Vice President, Head of R&D Division of Hanmi Pharm stated, "The paradigm of obesity treatment is evolving beyond simple weight reduction toward improving body composition and
More news about: Hanmi Pharm. Co., Ltd.
Aug 23, 2026, 23:05 ET Pulnovo Medical Announces First Two U.S. Patients Enrolled in PULSE-LHD IDE Clinical Trial of Pulmonary Artery Denervation in Treating Pulmonary Hypertension Associated with Left Heart Disease
[1] Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiery JL. Left ventricular heart failure and pulmonary hypertension. European heart journal. 2016 Mar 21;37(12):942-54.
More news about: Pulnovo Medical
Aug 23, 2026, 21:54 ET Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
driving long-term efforts to establish global clinical infrastructure for its lead pipelines, expand global strategic partnerships, and recruit top-tier R&D researchers in the U.S."Joining Lilly Gateway Labs in San Diego represents a meaningful milestone for Rznomics' proprietary RNA platform," said
More news about: Rznomics
Aug 23, 2026, 21:00 ET Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D
costimulatory moieties, further broadening our comprehensive TCE engineering toolbox. We are also deepening the integration of AI across our R&D engine. By linking multi-omics analysis with internally generated protein datasets, our AI platform identifies novel targets and target combinations,
More news about: Antengene Corporation Limited
Aug 23, 2026, 02:00 ET New Taipei's Tech Ecosystem Leaps into the Middle East: 20 Companies to Showcase at LEAP 2026
will present a diverse portfolio of innovative technologies, smart applications, and integrated solutions, highlighting New Taipei companies' strong R&D capabilities and ability to deliver customized services. The pavilion will provide global buyers with a broad range of competitive partnership opportunities.The
More news about: New Taipei City Government
Aug 22, 2026, 12:00 ET Genye Technology Opens New LA-Area Branch and Technology Demonstration Center in Southern California
normally require a trip to the manufacturing facility can now be answered locally.The center also creates a direct feedback loop between Genye's R&D teams and the North American market. Feedback from hands-on testing and customer discussions flows directly back to product development, speeding up
More news about: Genye Technology
Aug 22, 2026, 04:01 ET Chandigarh University Hosts Global Architectural Voices to Deliberate on Technology, Heritage and Future of Architecture
https://mmx.prnewswire.com/media/MS1973975/ICTAC_event_collage_group_top_speakers_below.jpg?id=OA2903341&token=eyJhbGciOiJkaXIiLCJlbmMiOiJBMjU2R0NNIn0..vyIt1-Qpobw4ZX4W.1QxGS5VNCjhZxaRW63yXMYGuyzRl3V5MN026BJrGy-idYn6FksvyBs_KeGyGGF7bW3cGTm1K5dNvwn7BjCyidmdcdgF5-3NcXTllKXG8B_gTzNjzLaZtpoAyvN48-dr5oIs.O8b-cgZp-R0v_7scTU0tvg
More news about: Chandigarh University
Aug 21, 2026, 22:29 ET Global Times: China's economic performance will remain within a reasonable range in H2, meet annual goals
the Chinese government's efforts to boost domestic demand, safeguard and improve people's livelihoods, strengthen public services, and enhance local R&D capabilities will bring bright prospects to the Chinese economy and also create new scenarios and opportunities for multinational companies to deepen
More news about: Global Times
Aug 21, 2026, 20:40 ET Morpho lance une imprimante UV de bureau sur Kickstarter, réinventant ainsi le travail créatif grâce à une nouvelle vision
développeurs informatiques, de concepteurs de produits et d'experts en fabrication. Le fondateur, Mingyu « Brett » Wang, a déjà dirigé les équipes de R&D et d'ingénierie chez DJI et détient plus de 500 brevets internationaux. Pour Wang, Morpho est un outil intuitif et fiable qui met la création physique
More news about: Morpho